SSRIs and Breastfeeding: What the Data Show

Are antidepressants safe while breastfeeding?

Antidepressants are among the most studied medications in breastfeeding, and major bodies treat most of them as compatible with nursing. The American Academy of Pediatrics notes that the great majority of maternal medications are compatible with breastfeeding and points clinicians to the NIH LactMed database for drug-specific detail 1Ref 1Meek JY, Noble L; Section on Breastfeeding (American Academy of Pediatrics) (2022).Policy Statement: Breastfeeding and the Use of Human Milk.AAP policy statement that the great majority of maternal medications are compatible with breastfeeding (directing clinicians to LactMed) and recommending exclusive breastfeeding for about 6 months with continuation to 2 years or beyond.. That framing matters, because the AAP also recommends exclusive breastfeeding for about 6 months and continued breastfeeding for 2 years or beyond 1Ref 1Meek JY, Noble L; Section on Breastfeeding (American Academy of Pediatrics) (2022).Policy Statement: Breastfeeding and the Use of Human Milk.AAP policy statement that the great majority of maternal medications are compatible with breastfeeding (directing clinicians to LactMed) and recommending exclusive breastfeeding for about 6 months with continuation to 2 years or beyond..

According to this evidence, the answer describes trade-offs rather than a single rule. Whether medication is safe while breastfeeding depends on the specific drug, the amount, the baby's age and health, and the parent's needs. A clinician weighs those together instead of applying a blanket yes or no.

How much medication reaches breast milk?

Only a fraction of a parent's dose typically reaches breast milk, and the amount differs sharply between drugs. Clinicians often describe this as the relative infant dose — the share of the parent's weight-adjusted dose that a fully breastfed baby receives. Sertraline and paroxetine are among the better-studied SSRIs and are frequently described in clinical references as having low transfer, while fluoxetine has a longer-acting metabolite that can build up more in some infants.

These are general patterns, not guarantees, and precise levels vary. Because the data are drug-specific, the NIH LactMed database and a clinician are better guides than any single headline number. The same questions come up in pregnancy, where antidepressants during pregnancy are weighed against different risks.

What does leaving depression untreated cost?

Untreated perinatal depression is not a neutral option — it carries real risks for the parent and for the developing bond with the baby. National guidance treats screening and treatment as important precisely because untreated symptoms can impair functioning, bonding, and safety 2Ref 2American College of Obstetricians and Gynecologists (2018).ACOG Committee Opinion No. 757: Screening for Perinatal Depression.ACOG recommendation to screen for perinatal depression at least once in the perinatal period and to ensure follow-up, reflecting the importance of treating rather than overlooking symptoms.3Ref 3Office on Women's Health (U.S. HHS) (2023).Postpartum depression.Federal women's-health overview describing the risks of untreated postpartum depression for parent and infant and the range of effective treatments.. A Cochrane review found antidepressants more effective than placebo for postnatal depression, though the evidence base is modest 4Ref 4Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K (2014).Antidepressant treatment for postnatal depression.Cochrane review finding antidepressants more effective than placebo for postnatal depression, while noting the evidence base is modest..

About 1 in 7 people who give birth experience perinatal depression, according to national health agencies 5Ref 5National Institute of Mental Health (2023).Perinatal Depression.National overview reporting that perinatal depression affects roughly 1 in 7 people who give birth and can occur during pregnancy or after delivery.. For milder symptoms, psychological therapies work well and involve no medication exposure at all; reviews support their role in preventing and easing postpartum depression 6Ref 6Dennis CL, Dowswell T (2013).Psychosocial and psychological interventions for preventing postpartum depression.Cochrane review supporting the role of psychosocial and psychological interventions, which involve no medication exposure, in reducing postpartum depression.. The American College of Obstetricians and Gynecologists recommends screening at least once in the perinatal period 2Ref 2American College of Obstetricians and Gynecologists (2018).ACOG Committee Opinion No. 757: Screening for Perinatal Depression.ACOG recommendation to screen for perinatal depression at least once in the perinatal period and to ensure follow-up, reflecting the importance of treating rather than overlooking symptoms..

What should you watch for in the baby?

Most breastfed infants whose parents take an SSRI show no obvious effects, but clinicians still suggest simple monitoring 1Ref 1Meek JY, Noble L; Section on Breastfeeding (American Academy of Pediatrics) (2022).Policy Statement: Breastfeeding and the Use of Human Milk.AAP policy statement that the great majority of maternal medications are compatible with breastfeeding (directing clinicians to LactMed) and recommending exclusive breastfeeding for about 6 months with continuation to 2 years or beyond.. Things worth noting include unusual sleepiness, poor feeding, irritability, or slowed weight gain — especially in newborns and premature babies, whose systems clear medication more slowly. A pediatrician can help track these alongside normal newborn changes.

Timing and drug choice can be adjusted if a concern comes up, which is one reason continuity with a clinician matters. Sharing the full picture — the medication, the feeding plan, and how the baby is doing — lets the care team respond. Knowing the link between breastfeeding and mood can also ease the worry that feeding choices alone drive how a parent feels.

When breastfeeding and depression need a clinician

Depression while breastfeeding is common, treatable, and worth a real conversation rather than a solo guess from a drug label. A clinician — an obstetric provider, primary care clinician, or behavioral health specialist — can match the approach to your symptoms, your feeding goals, and your baby's age, and can loop in a pediatrician as needed 2Ref 2American College of Obstetricians and Gynecologists (2018).ACOG Committee Opinion No. 757: Screening for Perinatal Depression.ACOG recommendation to screen for perinatal depression at least once in the perinatal period and to ensure follow-up, reflecting the importance of treating rather than overlooking symptoms.3Ref 3Office on Women's Health (U.S. HHS) (2023).Postpartum depression.Federal women's-health overview describing the risks of untreated postpartum depression for parent and infant and the range of effective treatments.. Some parents choose therapy first; others start medication; many combine both. Telling postpartum depression from the baby blues is often the first step. Gale can help you prepare for that visit. If low mood comes with thoughts of self-harm, that is a reason to seek help the same day.